Your browser doesn't support javascript.
loading
A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE).
Platt, Heather L; Cardona, Jose F; Haranaka, Miwa; Schwartz, Howard I; Narejos Perez, Silvia; Dowell, Anthony; Chang, Chih-Jen; Dagan, Ron; Tamms, Gretchen M; Sterling, Tina; Morgan, Leslie; Shi, Yaru; Pedley, Alison; Musey, Luwy K; Buchwald, Ulrike K.
  • Platt HL; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Cardona JF; Indago Research & Health Center, Inc., Hialeah, FL, USA.
  • Haranaka M; SOUSEIKAI PS Clinic, Fukuoka, Japan.
  • Schwartz HI; Research Centers of America, LLC, Hollywood, FL, USA.
  • Narejos Perez S; CAP Centelles, Barcelona, Spain.
  • Dowell A; Dynamik Research, Quebec, Canada.
  • Chang CJ; National Cheng Kung University Hospital, Tainan, Taiwan.
  • Dagan R; Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Tamms GM; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Sterling T; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Morgan L; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Shi Y; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Pedley A; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Musey LK; Merck & Co., Inc., Kenilworth, NJ, USA.
  • Buchwald UK; Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: ubuchwa1@jhmi.edu.
Vaccine ; 40(1): 162-172, 2022 01 03.
Article en En | MEDLINE | ID: mdl-34507861

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Anticuerpos Antibacterianos Tipo de estudio: Clinical_trials Límite: Adult / Humans / Middle aged Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Anticuerpos Antibacterianos Tipo de estudio: Clinical_trials Límite: Adult / Humans / Middle aged Idioma: En Año: 2022 Tipo del documento: Article